OTC

Strength

18; 200; 10 mg/15mL; mg/15mL; mg/15mL

NDC

58809055508

Classification

Brand

Dosage Form

LIQUID

Route

ORAL

Last Updated

1/21/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/1/2013

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-0.1%

1Y

-0.1%

3Y

+0.8%

5Y

+0.8%

All

-4.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.